The Center for Independence, a non-profit that empowers individuals with disabilities to live independently, will host a Low ...

Vaxart reported a net loss of $14.1 million for the third quarter of 2024, compared to $17.4 million for the third quarter of 2023. Net loss per share for the third quarter of 2024 was $0.06, compared ...

A new paper shows how partnering with the community can lead to more inclusive health care, especially for individuals with ...

Two senior Biden administration officials warned there could be serious consequences for the nation’s children if it had to ...

Health agencies, counties and state officials have been resisting efforts to provide booster jabs to Americans this fall.

Hope is on the horizon for needle-phobic patients as Griffith University researchers have created a new influenza vaccine ...

A groundbreaking study introduces stable inhalable mRNA treatment using nanoparticles that hold up during nebulization, ...

Hope is on the horizon for needle-phobic patients as Griffith University researchers have created a new influenza vaccine ...

Partners’ data continues to support PharmaJet’s Tropis ® and Stratis ® Needle-free Delivery Systems as optimal methods for ...

The Global Needle Free Injectors Market is projected to grow from USD 1,478.9 Million in 2024 to USD 2,980.9 Million by 2033, ...

I was in a private room and a pharmacist checked my health and if I had any allergies and then asked me to confirm some ...

On September 20, 2024, the U.S. Food and Drug Administration (FDA) approved the first influenza (flu) vaccine for at‑home use. The vaccine, ...